Praxis Precision Medicines to Present at J.P. Morgan Healthcare Conference
PRAX 01.06.2025
Date of Upcoming Event:2025-01-15
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) --Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be presenting a corporate overview at the 43rd Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA at the Westin St. Francis Hotel on Wednesday, January 15, 2025 at 2:15pm PST.
A live webcast of the event will be available through thislink. A replay of the event will also be available through the “Upcoming & Recent Events” page of the Investors + Media section of the company’s website atwww.praxismedicines.com, for 30 days.
About PraxisPraxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, CerebrumTM, and antisense oligonucleotide (ASO) platform, SolidusTM, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across movement disorders and epilepsy, with four clinical-stage product candidates. For more information, please visitwww.praxismedicines.comand follow us onFacebook,LinkedInandTwitter/X.
Investor Contact:Praxis Precision Medicinesinvestors@praxismedicines.com857-702-9452Media Contact:Dan FerryLifeSci AdvisorsDaniel@lifesciadvisors.com617-430-7576